Students find AI isn't a cure all for drug discovery

Northeastern graduate students found that current AI models, including popular open-source frameworks, still make critical errors and cannot independently replicate human-designed drug discovery algorithms or draft well-sourced scientific reports. This reveals that AI is not yet a standalone solution in drug discovery despite significant industry hype and investment.

This Wire brief sits within Fusion42's coverage of Drug Discovery.